Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Diclofenac

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 3

diclofenac

(dye kloe' fen ak)

diclofenac potassium
Cataflam, Voltaren Rapide (CAN)

diclofenac sodium
Novo-Difenac (CAN), Nu-Diclo (CAN), Solaraze, Voltaren, Voltaren Ophtha
(CAN), Voltaren-XR

Pregnancy Category B

Drug classes
Anti-inflammatory
NSAID

Therapeutic actions
Inhibits prostaglandin synthetase to cause antipyretic and anti-inflammatory effects; the
exact mechanism is unknown.

Indications
• Acute or long-term treatment of mild to moderate pain, including dysmenorrhea
• Rheumatoid arthritis
• Osteoarthritis
• Ankylosing spondylitis
• Treatment of actinic keratosis in conjunction with sun avoidance
• Ophthalmic: Postoperative inflammation from cataract extraction

Contraindications and cautions


• Contraindicated with allergy to NSAIDs, significant renal impairment, pregnancy,
lactation.
• Use cautiously with impaired hearing, allergies, hepatic, cardiovascular, and GI
conditions.

Available forms
Tablets—50 mg; DR tablets—25, 50, 75 mg; ER tablets—100 mg; topical gel—30 mg/g;
ophthalmic solution—0.1%

Dosages
ADULTS
Oral
• Pain, including dysmenorrhea: 50 mg tid PO; initial dose of 100 mg may help
some patients (Cataflam).
• Osteoarthritis: 100–150 mg/day PO in divided doses (Voltaren); 50 mg bid–tid
PO (Cataflam).
• Rheumatoid arthritis: 150–200 mg/day PO in divided doses (Voltaren); 50 mg
bid–tid PO (Cataflam).
• Ankylosing spondylitis: 100–125 mg/day PO. Give as 25 mg qid, with an extra
25-mg dose hs (Voltaren); 25 mg qid PO with an additional 25 mg hs if needed
(Cataflam).
Topical
• Actinic keratosis: Cover lesion with gel and smooth into skin; do not cover with
dressings or cosmetics.
Ophthalmic
1 drop to affected eye qid starting 24 hr post-op for 2 wk
PEDIATRIC PATIENTS
Safety and efficacy not established.

Pharmacokinetics
Route Onset Peak Duration
Oral (sodium) Varies 2–3 hr 12–15 hr
Oral (potassium) Rapid 20–120 min 12–15 hr

Metabolism: Hepatic; T1/2: 1.5–2 hr


Distribution: Crosses placenta; enters breast milk
Excretion: Urine and feces

Adverse effects
• CNS: Headache, dizziness, somnolence, insomnia, fatigue, tiredness, tinnitus,
ophthamologic effects
• Dermatologic: Rash, pruritus, sweating, dry mucous membranes, stomatitis
• GI: Nausea, dyspepsia, GI pain, diarrhea, vomiting, constipation, flatulence
• GU: Dysuria, renal impairment
• Hematologic: Bleeding, platelet inhibition with higher doses
• Other: Peripheral edema, anaphylactoid reactions to fatal anaphylactic shock

Interactions
Drug-drug
• Increased serum levels and increased risk of lithium toxicity
• Increased risk of bleeding with anticoagulants; monitor patient closely

Nursing considerations
Assessment
• History: Renal impairment; impaired hearing; allergies; hepatic, CV, and GI
conditions; lactation
• Physical: Skin color and lesions; orientation, reflexes, ophthalmologic and
audiometric evaluation, peripheral sensation; P, edema; R, adventitious sounds;
liver evaluation; CBC, clotting times, renal and liver function tests; serum
electrolytes, stool guaiac

Interventions
• Administer drug with food or after meals if GI upset occurs.
• Arrange for periodic ophthalmologic exam during long-term therapy.
• Institute emergency procedures if overdose occurs (gastric lavage, induction of
emesis, supportive therapy).

Teaching points
• Take drug with food or meals if GI upset occurs.
• Take only the prescribed dosage.
• These side effects may occur: Dizziness, drowsiness (avoid driving or using
dangerous machinery while using this drug).
• Report sore throat, fever, rash, itching, weight gain, swelling in ankles or fingers,
changes in vision; black, tarry stools.

Adverse effects in Italic are most common; those in Bold are life-threatening.

You might also like